ArticleHeart rhythm2010

Power and pitfalls of using transgenic mice to optimize therapy for CPVT: a need for prospective placebo-controlled clinical trials in genetic arrhythmia disorders.

Björn C KnollmannPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.